Madrigal Pharmaceuticals, Inc.
MDGL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001157601
In the last 90 days, Madrigal Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 3 sales; 414 institutions reported holding it in 13F filings for Q2 2026, worth $12.7B in total; no superinvestor holds it.
13F holders, Q2 2024
Institutional positions in Madrigal Pharmaceuticals, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 257
- −6 vs. Q1 2024
- Shares held
- 22.9M
- +1.79M (+8.5%) vs. Q1 2024
- Total value
- $6.41B
- +$777.9M (+13.8%) vs. Q1 2024
- New holders
- 49
- 111 more added
- Sold out
- 55
- 64 more reduced
3 institutions that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MDGL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 414 | $12.7B |
| Q1 2026 | 380 | $12.4B |
| Q4 2025 | 387 | $13.7B |
| Q3 2025 | 352 | $10.7B |
| Q2 2025 | 305 | $7.13B |
| Q1 2025 | 321 | $7.85B |
| Q4 2024 | 283 | $7.08B |
| Q3 2024 | 257 | $4.77B |
| Q2 2024 | 257 | $6.41B |
| Q1 2024 | 266 | $5.64B |
| Q4 2023 | 226 | $4.57B |
| Q3 2023 | 206 | $2.54B |
| Q2 2023 | 208 | $3.43B |
| Q1 2023 | 223 | $3.36B |
| Q4 2022 | 189 | $3.86B |
| Q3 2022 | 135 | $763.2M |
| Q2 2022 | 138 | $857.7M |
| Q1 2022 | 140 | $1.20B |
| Q4 2021 | 144 | $1.01B |
| Q3 2021 | 133 | $876.5M |
| Q2 2021 | 151 | $1.09B |
| Q1 2021 | 137 | $1.43B |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Madrigal Pharmaceuticals, Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Quantbot Technologies LP | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| ICA Group Wealth Management, LLC | 0 | $0 | 0.00% | −90−100.0% | Sold out |
| CoreCap Advisors, LLC | 0 | $0 | 0.00% | −68−100.0% | Sold out |
| Headlands Technologies LLC | 0 | $0 | 0.00% | −61−100.0% | Sold out |
| Leonteq Securities AG | 0 | $0 | 0.00% | −40−100.0% | Sold out |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 0 | $0 | 0.00% | −29−100.0% | Sold out |
| Meeder Asset Management Inc | 0 | $0 | 0.00% | −10−100.0% | Sold out |
| Bokf, NA | 0 | $0 | 0.00% | −10−100.0% | Sold out |
| Farmers & Merchants Trust Co of Chambersburg PA | 0 | $0 | 0.00% | −8−100.0% | Sold out |
| Westend Capital Management, LLC | 0 | $0 | 0.00% | −4−100.0% | Sold out |
| Riggs Asset Managment Co. Inc. | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| Atlas Capital Advisors LLC | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Cutler Group LP | – | – | – | – | Not filed |
| Credit Suisse AG | – | – | – | – | Not filed |
| Cambridge Trust Co | – | – | – | – | Not filed |